View the public protocol
AbbVie, Harvard Pilgrim Health Care Institute, Reagan-Udall Foundation for FDA, CVS Health, Carelon Research, Humana HealthCare Research, Health Partners Institute. Pregnancy Exposures and Outcomes in Women with Inflammatory Bowel Disease Treated with Risankizumab: A Cohort Study Utilizing Large Electronic Healthcare Databases with Mother-Baby Linkage in the United States (EUPAS1000000283; P23-653). Amsterdam: European Medicines Agency (EMA); 2024 Aug 6. Available from: https://catalogues.ema.europa.eu/node/4184
